XPA and skin cancer: Our data from the pooling analysis, FPRP analysis and TSA demonstrated a significant difference between skin cancer cases and negative controls under six genetic models, suggesting the contribution of the G allele within XPA rs1800975 to an enhanced susceptibility to skin cancer.